Caris Life Sciences: Chadi Nabhan
Caris Life Sciences has appointed Chadi Nabhan as chairman of its Precision Oncology Alliance, a collaborative network of 36 academic, hospital, and community-based cancer institutions focused on precision medicine. Nabhan was previously chief medical officer of Aptitude Health. Prior to that he was CMO at Cardinal Health Specialty Solutions. Nabhan was also an associate professor of medicine and medical director of the Clinical Cancer Center at the University of Chicago. He is currently an adjunct professor in the Department of Clinical Pharmacy at the University of South Carolina.
Inflammatix: João Fonseca
Inflammatix has appointed João Fonseca as chief technology officer to oversee its molecular assay development and engineering teams as the firm advances its rapid tests for acute infections, sepsis, and COVID-19 risk stratification.
Since 2006, Fonseca has served as founder, CEO, and chief scientific officer of Biosurfit, a Lisbon, Portugal-based company whose blood tests diagnose multiple conditions at the point of care. The companys tests are broadly available throughout Europe.
Prior to Biosurfit, Fonseca was a professor in physics and experimental physics at the Technical University of Lisbon and a researcher at the University of Lisbon. He also founded a non-profit organization that works with patients and researchers to advance novel cancer treatments and research.
Molecular Assemblies: Todd Peterson
Synthetic DNA maker Molecular Assemblies has appointed Todd Peterson, chief scientific officer of the Allen Institute, to its board of directors.
He brings more than 35 years of experience in research and development, having also held leadership positions at Synthetic Genomics and Life Technologies, now part of Thermo Fisher Scientific. At Synthetic Genomics, he was CTO and at Life Technologies he led synthetic biology and genomics R&D.
Peterson holds a doctorate in microbiology from the University of Southern California.
For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.